Cary Street Partners Investment Advisory LLC Teva Pharmaceutical Industries LTD Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $97 - $139	13 New	13 $0
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $5,962 - $7,110	750 New	750 $6,000
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $1,291 - $1,655	-150 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $1,285 - $1,903	150 New	150 $1,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$734 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$619 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$590 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account